Introduction: Thymic epithelial tumors (TETs), including thymomas and thymic carcinomas, are the predominant neoplasms of the anterior mediastinum. High-risk TETs have poor outcomes because of invasion and metastasis. Current diagnosis relies on computed tomography and invasive biopsy, which have limited specificity and scalability. Serum metabolic profiling offers a minimally invasive alternative, but conventional organic matrices for matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) cause substantial low-mass background and limited sensitivity.
Methods: An Fe-based metal-organic framework (Fe-MOF) was synthesized by a sonication-assisted water-bath method and partially pyrolyzed at 350-500 °C to generate Fe₃O₄@Fe-MOF heterojunctions. FM-450, produced at 450 °C, exhibited optimal analytical performance. Serum metabolic fingerprints (SMFs) were acquired by laser desorption/ionization mass spectrometry (LDI-MS) from 1 μL of serum from 163 patients with TETs and 80 benign controls (BCs). After spectral processing, machine-learning algorithms were used to construct diagnostic and risk-stratification models.
Results and Discussion: FM-450 combines the photothermal conversion efficiency of Fe₃O₄ nanoparticles with the ultraviolet absorption of the Fe-MOF framework to enhance the laser response. Its interfacial S-scheme heterojunction further promotes charge separation, thereby facilitating metabolite desorption and ionization. These synergistic properties increased metabolite signal intensities by up to 1,000-fold compared with CHCA and DHB, reduced low-mass background interference, and yielded coefficients of variation (CVs) of 4.1%-15.0%. Integration with an automated spotter enabled analysis within 14 s per sample, operational CVs below 10%, and an estimated matrix cost of $0.03 per test. The platform distinguished TETs from BCs (AUC = 0.960) and stratified high- and low-risk TETs (AUC = 0.856), exceeding imaging-based risk assessment (AUC = 0.627). Pathway analysis identified dysregulation of glycerolipid metabolism, the citrate cycle, and pyruvate metabolism.
Conclusions: Fe-MOF serves as both the structural precursor and ultraviolet-absorbing component of FM-450. Combined with Fe₃O₄-mediated photothermal conversion, the resulting heterojunction provides the functional basis for sensitive LDI-MS and enables rapid, high-throughput, minimally invasive metabolic diagnosis and risk stratification of TETs.